研究标题很长:SWOG S1826， a randomized study of nivolumab-AVD versus brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma 。
参考来源:1.M. J. Dickinson， J. Trotman， L. Berkahn. et al. PEMBROLIZUMAB AS FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD-INELIGIBLE PATIENTS， ALLOWS SUBSEQUENT THERAPY， AND GIVES ADEQUATE SURVIVAL. 2023 ICML. Abstract 106.
